While the optimized timing of cART initiation after starting anti-TB therapy has not been determined, the results of our study indicate that the initiation of cART within 4–8 weeks after the start of anti-TB treatment could improve the survival outcome, especially for patients with low CD4+ T cell counts. Here, CD4 is linked to tuberculosis.